This being said, it is important to appreciate that the type of NUTM1 fusion may not be the only variable that determines the distinct prognosis for each of the nonthoracic groups (A and B), because these groups include a small number of heterogenous patients; thus, other variables, including differences in treatment and tumor location, may contribute to the differences in outcome in these groups. Here, NUTM1 is linked to neoplasm.